Fagron company profile
Fagron was founded in Rotterdam (the Netherlands) in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in pharmaceutical compounding in the Netherlands in just 7 years.
Fagron’s successful strategy of optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide and improving patients’ quality of life. Its unique business model and the investments in innovation and product development resulted in the fact that Fagron is currently leading in pharmaceutical compounding and is active in 35 countries in Europe, the Americas, the Middle East, Africa, Asia and the Pacific. Fagron products and innovations are sold to over 200,000 customers in over 60 countries around the world.
With over 2,000 employees Fagron generated turnover of € 437 million in 2017. In 2018, Fagron will further reinforce its worldwide market leadership based on an active buy-and-build strategy and organic growth.
The Belgian company Fagron NV is located in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. The operational activities of Fagron are driven by the Dutch company Fagron BV. The head office of Fagron BV is located in Rotterdam (the Netherlands).